Case Report| Volume 19, ISSUE 3, PB7, March 2018

Download started.


Low Dose Steroid Replacement Therapy Causes Hepatitis B Virus Reactivation in Long-term Health Care Facility Patient

      We present a case of HBV reactivation in a post-acute long-term patient on low dose steroid replacement therapy. Low dose steroid replacement therapy is not well described as a cause HBV reactivation. This case illustrates that long-term facility residents are at risk of HBV reactivation with low dose steroid replacement therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect